VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$1.07
+0.01 (+0.94%)
Financial Highlights (FY 2026)
Revenue
266.6K
Net Income
-4,605,408
Gross Margin
96.5%
Profit Margin
-1,727.8%
Rev Growth
-54.2%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 96.5% 96.5% 53.9% 53.9%
Operating Margin -8,761.1% -7,885.0% 10.2% 11.9%
Profit Margin -1,727.8% -1,641.4% 12.7% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 266.6K 582.2K 3.56M 2.77M
Gross Profit 257.3K 562.0K 1.92M 1.49M
Operating Income -23,355,980 -45,906,053 363.1K 329.5K
Net Income -4,605,408 -9,051,904 452.9K 261.8K
Gross Margin 96.5% 96.5% 53.9% 53.9%
Operating Margin -8,761.1% -7,885.0% 10.2% 11.9%
Profit Margin -1,727.8% -1,641.4% 12.7% 9.5%
Rev Growth -54.2% -54.2% +0.2% +7.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.21M 2.49M
Total Equity 4.37M 4.42M
D/E Ratio 0.51 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -22,860,426 -47,428,269 509.0K 375.7K
Free Cash Flow 445.4K 284.4K